Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.

Journal article

Santana González L. et al, (2021), Dis Model Mech, 14

Promises and challenges of adoptive T-cell therapies for solid tumours

Journal article

Morotti M. et al, (2021), British Journal of Cancer, 124, 1759 - 1776

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Journal article

Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Journal article

Santana Gonzalez L. et al, (2021), Frontiers in Cellular and Infection Microbiology

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct

Journal article

Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology, 9

The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

Journal article

Hu Z. et al, (2021), Clinical Cancer Research, 27, 1570 - 1579

Novel SIK2 inhibitors sensitize ovarian and breast cancer to PARP inhibitors

Conference paper

Lu Z. et al, (2020), CANCER RESEARCH, 80

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells

Conference paper

Prota G. et al, (2020), Cancer Immunology Research, 8, 685 - 697

"Enhancing tumour specific immune responses for the treatment of ovarian cancer"

Journal article

AHMED A. and CERUNDOLO V., (2020), Cancer Immunology Research

Enhanced immunogenicity of mitochondrial localised proteins in cancer cells

Journal article

CERUNDOLO V. et al, (2020), Cancer Immunology Research

Load More